-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Gilead Sciences, Raises Price Target to $175

Benzinga·10/30/2026 19:31:42
语音播报
TD Cowen analyst Tyler Van Buren maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $160 to $175.